newsfilter
← Latest News
GlobeNewswire·

Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain

TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of